
Gzide Total 60mg/15mg/500mg Tablet SR
Marketer
Elder Projects Ltd
Salt Composition
Gliclazide (60mg) + Pioglitazone (15mg) + Metformin (500mg)
Overview Gzide Total 60mg/15mg/500mg Tablet SR
Diabetic patients with type 2 diabetes mellitus can manage their blood glucose levels with the extended-release Gzide Total 60mg/15mg/500mg tablet. This medication should be ingested with meals, consistently at the same time daily, as prescribed by your physician. Dosage adjustments may occur based on blood sugar monitoring. Discontinuing this medication without medical consultation can lead to uncontrolled blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medicine is one element of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, and headaches. Carry a rapid-acting glucose source (e.g., sugary food or juice) to address this. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other possible side effects are nausea, altered taste, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, as well as blood tests to assess blood cell counts and liver function, are necessary.
Uses of Gzide Total 60mg/15mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gzide Total 60mg/15mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Gzide Total 60mg/15mg/500mg SR tablets with a meal.
Common Side effects of Gzide Total 60mg/15mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Bronchitis (inflammation of the airways)
- Anemia (low number of red blood cells)
- Edema (swelling)
How to use Gzide Total 60mg/15mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Gzide Total 60mg/15mg/500mg Extended-Release Tablets with food.
How Gzide Total 60mg/15mg/500mg Tablet SR works:
Gzide Total SR tablets (60mg/15mg/500mg) combine gliclazide, pioglitazone, and metformin—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual therapies prove insufficient. Gliclazide (a sulfonylurea) stimulates pancreatic insulin release, reducing blood glucose levels. Pioglitazone (a thiazolidinedione) improves insulin sensitivity. Metformin (a biguanide) acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and boosting insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Gzide Total 60mg/15mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gzide Total 60mg/15mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Gzide Total 60mg/15mg/500mg tablet is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The extended-release Gzide 60mg/15mg/500mg tablet is likely contraindicated for individuals with renal impairment and should be avoided. Seek medical advice before use.
LiverUNSAFE
The use of Gzide Total 60mg/15mg/500mg SR tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Seek medical counsel.
What if you forget to take Gzide Total 60mg/15mg/500mg Tablet SR :
Should you forget to take your Gzide Total 60mg/15mg/500mg Tablet SR, ingest the dose immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, forgo the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Gzide Total 60mg/15mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
